跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BREZTRI AEROSPHERE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BREZTRI AEROSPHERE
Authorized
STANDARD
BREZTRI AEROSPHERE
astrazeneca canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e0568959814fe207
Company
astrazeneca canada inc
Type
Standard
Approval Details
Approval Id
e0568959814fe207
Drug Approval Canada Name
BREZTRI AEROSPHERE
Product Name
BREZTRI AEROSPHERE
Status
Marketed
Status Date
2024-01-05
Original Market Date
2021-12-03
Din
02518058
Drug Class
Human
Dosage Form
Aerosol, Metered Dose
Route Of Administration
Inhalation
Schedule
Prescription
Ahfs
12:08.08
Atc Original
R03AL11 FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE
Atc Name
r 03 al 11
Aig Number
0363070002
Company Name
astrazeneca canada inc
Company Address
1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4
Active Ingredients
BUDESONIDE
160 MCG / ACT
FORMOTEROL FUMARATE DIHYDRATE
5 MCG / ACT
GLYCOPYRRONIUM (GLYCOPYRROLATE)
7.2 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e0568959814fe207
Type
Standard
Back to Health Canada Approvals